Diabetes

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about? Click through to find out. 

The new "sweet spot" in diabetes management is the interdisciplinary approach that is essential to treating all aspects of the disease. New diabetes medications also hit that spot.

ADA 2019 ICYMI: Tirzepatide, a GIP and GLP-1 receptor agonist, reduces A1c and BMI as well as biomarkers of metabolic dysfunction in type 2 diabetes patients. Four studies reviewed.

ADA 2019 ICYMI: Safety and efficacy of oral semaglutide in patients with T2DM was demonstrated in results of 3 PIONEER program clinical trials.  Highlights, here.

ADA 2019--Linagliptin, the DPP-4 inhibitor, showed similar risk for first or recurrent CV events or hopspitalization vs placebo in T2DM patients with high cardiorenal risk in CARMELINA subanalysis.

ADA 2019-Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.

A personal EKG monitor, an app that wirelessly connects to a smart thermometer, and 3 more FDA-cleared apps for primary care. 

Refresh your memory of 4 CGM systems that received FDA-approval in 2018. Each one offers innovative features to help enhance diabetes care.

Diabetes is a progressive disease and takes advantage of inaction. How would you manage our patient Mrs Davis?

Who is at risk for T2DM? How often should you screen? What are the cut offs for Dx? Revisit the basics in 5 minutes or less.

The Numbers: >90% of US adults aged ≥65 yrs have diabetes; 33% of those have T2DM; ~50% of older adults have prediabetes. We highlight new Endocrine Society treatment guidance.

More than one-third of those in recovery from drug/alcohol use have chronic physical disease. A novel study looks at prevalence of health issues by type of substance used.

From a mobile EKG monitor to a digital urinalysis app, these medical "devices" are changing the way healthcare is delivered.

Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.

Findings: a heart-healthy lifestyle reduces DM risk; 1 egg a day may protect against T2DM; and a new genetic risk score may improve DM diagnosis.

True or false? The rates of T2DM in people with SMI are up to 5 times higher vs the general population.

Help your patients with diabetes help themselves. See 5 apps at-a-glance you can discuss at the next visit.

Sample: True or false? The prevalence of undiagnosed diabetes is higher among obese adults vs overweight adults.

Up to 50% of patients with diabetes may have signficant neuropathy, yet be asymptomatic. Here's how to avoid or attenuate the condition.

Severe hypoglycemia was associated with death within ~1 week among patients with T2DM, according to a subanalysis of the LEADER trial.

True or False: In 2015, Americans spent more on insulin glargine than any other drug. The answer and 9 more questions in our quiz.

Results include: The metabolic dangers of neuroleptic Rx in youth; prevalence of T2DM in minorities with severe mental illness; and gaps in care for mentally ill with T2DM.

Anything less than comprehensive care for type 2 diabetes is quickly becoming old school.

What to do when patients face their own "clinical inertia"? Here, 3 simple ways to help them push through. 

Severe hypoglycemia is more prevalent than previously believed and also significantly underreported. Details from 3 studies at ADA 2018.